Your Real Competitor Isn’t Another Vendor—It’s the Buying Committee

How Deals Die Without Competition and What Elite Teams Do to Prevent “No Decision”

2.28.26

The Prediction

Here’s what 2026 is making unavoidable:

The deal you lost to “no decision” didn’t die in the market.

It died in the conference room.

For years, teams built competitive strategy around defeating vendors. Battlecards, win/loss analysis, pricing leverage, differentiation narratives. All useful. All optimized for the wrong adversary.

Your real opponent in 2026 isn’t another product. It’s the ten people inside your buyer’s organization who never aligned, never resolved their competing priorities, and eventually let the budget expire rather than make a call.

AI has streamlined discovery. Multi-threading has become mainstream advice. Pipeline generation is faster than ever. And yet “no decision” rates haven’t improved. They’ve gotten worse.

Because the problem was never the vendor comparison. It was the internal decision process—and most teams still treat that as the buyer’s job to navigate.

The teams winning in 2026 aren’t winning on product. They’re winning because they own the decision process itself.

Why This Breaks Teams at $10M–$50M ARR

The hidden assumption most scaling teams make:

If we have a strong champion and a compelling ROI story, deals close.

This assumption comes from a champion-centric sales model. Champions are necessary. They’re never sufficient.

Here’s how the failure actually shows up:

In pipeline reviews, reps report strong champion engagement and positive sentiment. But when you probe, the deal is single-threaded. One person carrying the internal sale across finance, legal, IT, procurement, and operations—none of whom have been directly engaged. The rep is winning the relationship. The organization is unconvinced.

In forecasting, “committed” deals slip quarter after quarter. The champion didn’t change their mind. Finance wanted a different ROI framing. Legal added a security review. Procurement surfaced a vendor policy no one planned for. The deal didn’t lose to a competitor. It suffocated under internal weight the rep never saw coming because they never mapped the full committee.

In board conversations, leadership sees the same frustrating pattern: strong pipeline, experienced reps, reasonable close rates—but a disproportionate share of late-stage deals evaporating as “no decision.” The diagnosis is usually “market uncertainty.” The real diagnosis: the team is selling the product, not the decision.

At $10M–$50M ARR, your deals are large enough to require multi-stakeholder alignment but your sales motion is still optimized for single-threaded persuasion.

If a significant portion of your late-stage pipeline is single-threaded beyond day 45, your forecast isn’t wrong—it’s structurally optimistic.

That mismatch doesn’t show up as a competitive loss. It shows up as a ghost—a deal that stops moving until it disappears.

$180K deal. Strong champion. “Commit” stage for two quarters. The rep had weekly calls, a signed business case, and verbal commitment from the VP of Operations. The CFO saw the proposal for the first time in a procurement review and killed it in 48 hours. Not because of price. Not because of a competitor. Because risk had never been framed for the one person who held final authority. The champion couldn’t rescue it. There was nothing to rescue—the CFO’s concerns had never been addressed because they’d never been surfaced.

This is not a pipeline problem. It’s a committee problem—and it’s preventable.

The Data

A few numbers matter here:

• 40–60% of B2B deals end in “no decision” — not lost to a competitor, but stalled by indecision.
​Large-scale analysis of more than 2.5 million B2B sales conversations found that between 40% and 60% of qualified pipeline ends without a decision. In 56% of those cases, buyers actually want to move forward — but hesitate out of fear of making the wrong call, not preference for the status quo. Source: Dixon & McKenna, The JOLT Effect (2022), based on analysis of 2.5M+ sales conversations.

• The average B2B purchase now involves 13 stakeholders, with 89% of purchases crossing two or more departments. Each applies a different lens: finance measures ROI, IT evaluates security and integration risk, procurement enforces vendor policy, operations owns implementation burden. No single champion navigates all of these simultaneously. Source: Forrester, The State of Business Buying, 2024

• 86% of B2B purchases stall at least once during the buying process.
The cause is almost never the vendor. It’s internal. A stakeholder’s concern goes unaddressed long enough to become a quiet veto. By the time it surfaces, it’s often too late for the rep to act. Source: Forrester, The State of Business Buying, 2024

• In 79% of purchases, the CFO holds final decision-making power, and legal teams slow or block deals 61% of the time. Yet finance and legal are typically the last stakeholders to be engaged—often introduced only at procurement review, when it’s too late to frame risk on your terms. The person who kills the deal is rarely the one your rep has been talking to. Source: G2, 2024 Buyer Behavior Report

The pattern is consistent across every data source in this series:

Deals don’t die because the champion lost faith.
They die because the committee never found it.

What Elite Teams Do Differently

Elite teams accept a hard truth:

The sale isn’t between your rep and the champion. It’s between your organization and a committee of people who don’t agree with each other.

Elite teams choose to map the committee before the deal advances—even though it slows single-thread velocity.

They don’t wait for the champion to introduce additional stakeholders. They ask upfront: “Who else will need to be comfortable with this decision before it’s made?” They surface the committee early, engage it before any member becomes a veto point, and equip champions with exactly what they need to sell internally: financial framing for the CFO, security documentation for IT, procurement-ready summaries for legal. Champions don’t “figure it out.” They’re equipped to win the internal sale.

Elite teams choose to sell the decision process itself—even though most teams have never done this.

They map approval paths, surface veto points early, and help buyers sequence their internal conversations. They ask: “What needs to be true for this to get approved?” and work backwards from that answer. Decision milestones replace deal milestones. Stage advancement only happens when internal alignment advances.

Elite teams choose to name the no-decision risk explicitly—even though it makes deals feel fragile.

They surface it as a shared problem: “The biggest risk to this project isn’t a competitor—it’s organizational inertia. Here’s how we help you neutralize it.” That framing is honest, differentiated, and far more useful than another competitive comparison.

The tradeoff elite teams accept: more pre-close complexity, harder conversations, smaller initial velocity. But the deals that advance close with durable committee confidence—not last-minute stalls that derail quarters.

The Operator Discipline

1. Map the committee before the deal advances. Every qualified opportunity must include a named stakeholder map: who influences, who approves, who can veto, and what each one cares about. If a rep can’t name five stakeholders and their individual priorities, the deal isn’t qualified.

2. Equip champions, don’t depend on them. Every active deal should include internal-facing assets tailored to the committee’s composition: financial framing, security and integration documentation, procurement summaries, and executive risk framing. If your champion is creating these from scratch, you’re already behind.

3. Sell the decision process, not just the product. Ask buyers directly: “What does your internal approval process look like? What would need to be true for this to get final sign-off?” Then help sequence those conversations—don’t leave them to chance.

4. Gate forecast confidence on committee engagement. No “commit” stage without confirmation that finance, IT, and procurement have been engaged. Single-threaded deals beyond day 45 should be flagged as pipeline risk—not committed revenue.

5. Name the no-decision risk early. Make it part of your deal strategy: “The most common reason organizations don’t move forward has nothing to do with the vendor—it’s internal alignment. Here’s what we do to help.” That conversation differentiates you and surfaces hidden veto risks before they kill the deal.

6. Measure speed-to-committee-engagement as a leading indicator. Track how quickly reps expand beyond their initial contact—and build this into your pipeline review cadence. Single-threaded deals at day 30 are an early warning. At day 45, they’re a forecast problem.

The Scaling Signal

Ask yourself:

• Can your reps name every stakeholder in their top five deals—and each one’s specific priority?

• Does your CRM reflect committee engagement, or just activity with a single contact?

• What percentage of your late-stage pipeline is single-threaded beyond day 45?

• When deals stall, do you ask what happened with the champion—or what happened with alignment?

• Do you have internal-ready assets for finance, IT, and procurement in every active deal?

If your answers skew champion-centric, your team is winning relationships and losing committees.

That gap doesn’t appear in your win/loss report. It shows up as “no decision”—the invisible revenue drain that never gets a post-mortem because there’s no loss to diagnose.

Series Continuity

This is Week 8 of the SalesGSS 2026 Operating Series. The final issue.

Over eight weeks, one pattern ran through every prediction:

• Week 1: AI doesn’t fix execution—it exposes it.

• Week 2: Closers still matter, but only if they can orchestrate consensus.

• Week 3: Long cycles aren’t killing deals—delayed value is.

• Week 4: Your roadmap is a liability. Your changelog is the sale.

• Week 5: Waiting for clean data is malpractice.

• Week 6: Slow teams don’t catch up.

• Week 7: Focus is the new revenue multiplier.

• Week 8: Your real competitor isn’t another vendor—it’s the buying committee.

The thread connecting all eight: execution breaks when teams optimize for the wrong thing. AI readiness. Data perfection. Individual persuasion. Roadmap ambition. Speed without focus. Expansion without discipline. All become liabilities when they substitute for the harder work of owning the outcome.

Every issue in this series points to the same underlying truth:

The teams that win in 2026 don’t just execute better. They own more of the process—internal and external—than anyone else is willing to.

———

The 2026 reality is already here.

The teams that treat consensus as their job will close deals competitors leave on the table.

The teams that don’t will keep explaining ghost pipeline to their board.

———

The SalesGSS 2026 Reality Reality Check is now complete.

Eight operating truths.
Eight failure modes.
Eight execution disciplines.

The CEOs, CROs and VP of Sales who apply this framework before Q2 will fix structural problems their competitors are still misdiagnosing.

The ones who don’t will recognize these patterns in hindsight—usually on a board call where the question is: why did we miss?

Reply “PLAYBOOK” and I’ll send you the full 2026 Revenue Reality Check—the complete series, the Velocity Diagnostic, and the execution scorecards.

———

This is part of the SalesGSS 2026 Revenue Operating Series.

Most teams read content.
A few teams build decision discipline.

SalesGSS is for the second group.

Forward this to the revenue leader navigating stalled deals and defending pipeline in the boardroom.

———

Sources

• Dixon & McKenna — The JOLT Effect (Portfolio/Penguin, 2022); analysis of 2.5M+ sales conversations

• Forrester — The State of Business Buying, 2024 (December 4, 2024)

• G2 — 2024 Buyer Behavior Report (survey of 1,900+ global B2B software buyers)